HOME Top Market Reports Molecular Diagnostics Market by Application (Infectious Disease (Hepatitis, HIV), Oncology, Genetic Testing), Technology (PCR, DNA Sequencing & NGS), End User (Hospital/Academic Laboratory), Product & Service (Reagent, Software) - Global Forecast to 2023

Molecular Diagnostics Market by Application (Infectious Disease (Hepatitis, HIV), Oncology, Genetic Testing), Technology (PCR, DNA Sequencing & NGS), End User (Hospital/Academic Laboratory), Product & Service (Reagent, Software) - Global Forecast to 2023

By: marketsandmarkets.com
Publishing Date: May 2018
Report Code: MD 2521

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global molecular diagnostics market is projected to reach USD 11.54 Billion by 2023 from USD 7.10 Billion in 2017, at a CAGR of 8.4%. The base year considered for the study is 2017, and the forecast for the market size is provided for the period between 2018 and 2023. Growth in this market is primarily driven by the high prevalence of infectious diseases and various types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market, and advancements in molecular techniques.

Objectives of the Study

  • To define, describe, and segment the global molecular diagnostics (MDx) market, by product and service, technology, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
  • To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW)
  • To profile the key players in the market and comprehensively analyze their market positions and core competencies
  • To track and analyze competitive developments such as acquisitions, product launches and approvals, expansions, and other developments in the market

Research Methodology

Both, top-down and bottom-up approaches were used to validate the size of the global molecular diagnostics market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research, and their market presence was studied through primary and secondary research. Secondary sources include annual reports, press releases, and investor presentations of companies; white papers; medical journals; certified publications; articles from recognized authors; gold standard and silver standard websites; directories; and databases. Primary research included extensive interviews with key opinion leaders such as CEOs, vice presidents, directors, marketing executives, and related key executives from various companies. The percentage splits, shares, and breakdowns of the segments were determined using secondary sources and verified through primary sources. This data is consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Molecular Diagnostics Market

To know about the assumptions considered for the study, download the pdf brochure

The key players in the global market are Roche (Switzerland), Hologic (US), QIAGEN (Netherlands), Abbott (US), and Danaher (US).

Target Audience

  • Manufacturers and distributors of molecular diagnostic instruments and assays
  • Hospital laboratories
  • Academic institutes
  • Research institutes
  • Reference laboratories
  • Diagnostics suppliers
  • Blood banks
  • Home health agencies
  • Market research and consulting firms
  • Regulatory bodies
  • Venture capitalists

Scope of the Report

The research report categorizes the global market into the following segments and subsegments:

  • Molecular Diagnostics Market, by Product & Service
    • Reagents & Kits
    • Instruments
    • Services & Software
  • Molecular Diagnostics Market, by Application
    • Infectious Diseases
      • Hepatitis
      • HIV
      • CT/NG
      • HAIs
      • HPV
      • TB
      • Influenza
      • Other Infectious Diseases
    • Oncology
      • Breast Cancer
      • Lung Cancer
      • Colorectal Cancer
      • Prostate Cancer
      • Other Cancers
    • Genetic Tests
    • Other Applications
  • Molecular Diagnostics Market, by Technology
    • PCR
    • INAAT
    • DNA Sequencing & NGS
    • In Situ Hybridization
    • DNA Microarrays
    • Other Technologies
  • Molecular Diagnostics Market, by End User
    • Hospitals & Academic Laboratories
    • Reference Laboratories
    • Other End Users
  • Molecular Diagnostics Market, by Region
    • North America
      • US
      • Canada
    • Europe
      • Germany
      • France
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia Pacific
      • Japan
      • China
      • Australia
      • India
      • Rest of APAC        
    • Rest of the World (RoW)
      • Latin America
        • Brazil
        • Mexico
        • Rest of Latin America
      • Middle East & Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

Product matrix, which gives a detailed comparison of the product portfolios of each company

Company Information

Detailed analysis and profiling of additional market players (up to 5)

Table of Contents

1 Introduction (Page No. - 22)
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Markets Covered
           1.2.2 Years Considered for the Study
    1.3 Currency
    1.4 Limitations
    1.5 Stakeholders

2 Research Methodology (Page No. - 26)
    2.1 Primary Data
           2.1.1 Key Data From Primary Sources
           2.1.2 Key Industry Insights
    2.2 Secondary Data
           2.2.1 Key Data From Secondary Sources
    2.3 Market Size Estimation
    2.4 Market Breakdown and Data Triangulation
           2.4.1 Assumptions for the Study

3 Executive Summary (Page No. - 34)

4 Premium Insights (Page No. - 39)
    4.1 Molecular Diagnostics: Market Overview
    4.2 Molecular Diagnostics Market, By Technology and Region, 2018
    4.3 Market, By Product and Service, 2018 vs 2023 (USD Billion)
    4.4 Market, By End User

5 Market Overview (Page No. - 42)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 High Prevalence of Infectious Diseases and Various Types of Cancers
                    5.2.1.2 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
                    5.2.1.3 Growth in the Biomarker Identification Market and Advancements in Molecular Techniques
           5.2.2 Restraints
                    5.2.2.1 Complex Regulatory Frameworks Delaying the Approval of New Molecular Diagnostic Tests
           5.2.3 Opportunities
                    5.2.3.1 Advances in Genomics and Proteomics
                    5.2.3.2 Growth Opportunities in Emerging Markets
           5.2.4 Challenges
                    5.2.4.1 Dearth of Trained Professionals Limiting the Appropriate Use of New Molecular Diagnostic Technologies

6 Molecular Diagnostics Market, By Product & Service (Page No. - 47)
    6.1 Introduction
    6.2 Reagents & Kits
    6.3 Instruments
    6.4 Services & Software

7 Molecular Diagnostics Market, By Technology (Page No. - 58)
    7.1 Introduction
    7.2 Polymerase Chain Reaction (PCR)
    7.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
    7.4 DNA Sequencing & Next-Generation Sequencing (NGS)
    7.5 in Situ Hybridization
    7.6 DNA Microarray
    7.7 Other Technologies

8 Molecular Diagnostics Market, By Application (Page No. - 78)
    8.1 Introduction
    8.2 Infectious Diseases
           8.2.1 Hepatitis
           8.2.2 HIV
           8.2.3 CT/NG
           8.2.4 HAIS
           8.2.5 HPV
           8.2.6 Tuberculosis
           8.2.7 Influenza
           8.2.8 Other Infectious Diseases
    8.3 Oncology
           8.3.1 Breast Cancer
           8.3.2 Colorectal Cancer
           8.3.3 Lung Cancer
           8.3.4 Prostate Cancer
           8.3.5 Other Cancers
    8.4 Genetic Tests
    8.5 Other Applications

9 Molecular Diagnostics Market, By End User (Page No. - 105)
    9.1 Introduction
    9.2 Hospital & Academic Laboratories
    9.3 Reference Laboratories
    9.4 Other End Users

10 Molecular Diagnostics Market, By Region (Page No. - 116)
     10.1 Introduction
     10.2 North America
             10.2.1 US
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 France
             10.3.3 Italy
             10.3.4 Spain
             10.3.5 UK
             10.3.6 Rest of Europe
     10.4 Asia Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 Australia
             10.4.4 India
             10.4.5 RoAPAC
     10.5 Rest of the World
             10.5.1 Latin America
                        10.5.1.1 Brazil
                        10.5.1.2 Mexico
                        10.5.1.3 Rest of Latin America
             10.5.2 Middle East & Africa

11 Competitive Landscape (Page No. - 173)
     11.1 Overview
     11.2 Market Share Analysis
     11.3 Molecular Diagnostics Market Competitive Share Analysis, By Application
             11.3.1 Market Share Analysis for Infectious Disease Applications
             11.3.2 Market Share Analysis, By Technology
                        11.3.2.1 Polymerase Chain Reaction (PCR)
                        11.3.2.2 DNA Sequencing and NGS
                        11.3.2.3 in Situ Hybridization (ISH)
     11.4 Competitive Situation and Trends
             11.4.1 New Product Launches and Approvals, 2016–2018
             11.4.2 Agreements, Partnerships, and Collaborations, 2016–2018
             11.4.3 Acquisitions and Mergers
             11.4.4 Expansions

12 Company Profiles (Page No. - 180)
Business Overview, Products Offered, Services Offered, Recent Developments, MnM View
     12.1 Abbott Laboratories
     12.2 Agilent Technologies
     12.3 Becton, Dickinson and Company
     12.4 Biomιrieux Sa
     12.5 Danaher Corporation
     12.6 Diasorin
     12.7 Grifols
     12.8 Hologic
     12.9 Illumina
     12.10 Qiagen
     12.11 Roche Diagnostics
     12.12 Siemens AG
     12.13 Thermo Fisher Scientific

*Details Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 234)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Introducing RT: Real-Time Market Intelligence
     13.4 Available Customizations
     13.5 Related Reports
     13.6 Author Details


List of Tables (221 Tables)

Table 1 New Tests Launched By Key Players
Table 2 Molecular Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 3 Molecular Diagnostic Reagents & Kits Market, By Region, 2016–2023 (USD Million)
Table 4 North America: Molecular Diagnostic Reagents & Kits Market, By Country, 2016–2023 (USD Million)
Table 5 Europe: Molecular Diagnostic Reagents & Kits Market, By Country/Region, 2016–2023 (USD Million)
Table 6 Asia Pacific: Molecular Diagnostic Reagents & Kits Market, By Country/Region, 2016–2023 (USD Million)
Table 7 RoW: Molecular Diagnostic Reagents & Kits Market, By Region, 2016–2023 (USD Million)
Table 8 Latin America: Molecular Diagnostic Reagents & Kits Market, By Country/Region, 2016–2023 (USD Million)
Table 9 Molecular Diagnostic Instruments Market, By Region, 2016–2023 (USD Million)
Table 10 North America: Molecular Diagnostic Instruments Market, By Country, 2016–2023 (USD Million)
Table 11 Europe: Molecular Diagnostic Instruments Market, By Country/Region, 2016–2023 (USD Million)
Table 12 Asia Pacific: Molecular Diagnostic Instruments Market, By Country/Region, 2016–2023 (USD Million)
Table 13 RoW: Molecular Diagnostic Instruments Market, By Region, 2016–2023 (USD Million)
Table 14 Latin America: Molecular Diagnostic Instruments Market, By Country/Region, 2016–2023 (USD Million)
Table 15 Molecular Diagnostic Services & Software Market, By Region, 2016–2023 (USD Million)
Table 16 North America: Molecular Diagnostic Services & Software Market, By Country, 2016–2023 (USD Million)
Table 17 Europe: Molecular Diagnostic Services & Software Market, By Country/Region, 2016–2023 (USD Million)
Table 18 Asia Pacific: Molecular Diagnostic Services & Software Market, By Country/Region, 2016–2023 (USD Million)
Table 19 RoW: Molecular Diagnostic Services & Software Market, By Region, 2016–2023 (USD Million)
Table 20 Latin America: Molecular Diagnostic Services & Software Market, By Country/Region, 2016–2023 (USD Million)
Table 21 Molecular Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 22 Market for PCR, By Region, 2016–2023 (USD Million)
Table 23 North America: Market for PCR, By Country, 2016–2023 (USD Million)
Table 24 Europe: Market for PCR, By Country/Region, 2016–2023 (USD Million)
Table 25 Asia Pacific: Market for PCR, By Country/Region, 2016–2023 (USD Million)
Table 26 RoW: Market for PCR, By Region, 2016–2023 (USD Million)
Table 27 Latin America: Market for PCR, By Country/Region, 2016–2023 (USD Million)
Table 28 Market for INAAT, By Region, 2016–2023 (USD Million)
Table 29 North America: Market for INAAT, By Country, 2016–2023 (USD Million)
Table 30 Europe: Market for INAAT, By Country/Region, 2016–2023 (USD Million)
Table 31 Asia Pacific: Molecular Diagnostics Market for INAAT, By Country/Region, 2016–2023 (USD Million)
Table 32 RoW: Market for INAAT, By Region, 2016–2023 (USD Million)
Table 33 Latin America: Market for INAAT, By Country/Region, 2016–2023 (USD Million)
Table 34 Market for DNA Sequencing and NGS, By Region, 2016–2023 (USD Million)
Table 35 North America: Market for DNA Sequencing and NGS, By Country, 2016–2023 (USD Million)
Table 36 Europe: Market for DNA Sequencing and NGS, By Country/Region, 2016–2023 (USD Million)
Table 37 Asia Pacific: Market for DNA Sequencing and NGS, By Country/Region, 2016–2023 (USD Million)
Table 38 RoW: Molecular Diagnostics Market for DNA Sequencing and NGS, By Region, 2016–2023 (USD Million)
Table 39 Latin America: Market for DNA Sequencing and NGS, By Country/Region, 2016–2023 (USD Million)
Table 40 Market for in Situ Hybridization, By Region, 2016–2023 (USD Million)
Table 41 North America: Market for in Situ Hybridization, By Country, 2016–2023 (USD Million)
Table 42 Europe: Molecular Diagnostics Market for in Situ Hybridization, By Country/Region, 2016–2023 (USD Million)
Table 43 Asia Pacific: Market for in Situ Hybridization, By Country/Region, 2016–2023 (USD Million)
Table 44 RoW: Market for in Situ Hybridization, By Region, 2016–2023 (USD Million)
Table 45 Latin America: Market for in Situ Hybridization, By Country/Region, 2016–2023 (USD Million)
Table 46 Molecular Diagnostics Market for DNA Microarray, By Region, 2016–2023 (USD Million)
Table 47 North America: Market for DNA Microarray, By Country, 2016–2023 (USD Million)
Table 48 Europe: Market for DNA Microarray, By Country/Region, 2016–2023 (USD Million)
Table 49 Asia Pacific: Market for DNA Microarray, By Country/Region, 2016–2023 (USD Million)
Table 50 RoW: Molecular Diagnostics Market for DNA Microarray, By Region, 2016–2023 (USD Million)
Table 51 Latin America: Market for DNA Microarray, By Country/Region, 2016–2023 (USD Million)
Table 52 Molecular Diagnostics Market for Other Technologies, By Region, 2016–2023 (USD Million)
Table 53 North America: Market for Other Technologies, By Country, 2016–2023 (USD Million)
Table 54 Europe: Market for Other Technologies, By Country/Region, 2016–2023 (USD Million)
Table 55 Asia Pacific: Market for Other Technologies, By Country/Region, 2016–2023 (USD Million)
Table 56 RoW: Molecular Diagnostics Market for Other Technologies, By Region, 2016–2023 (USD Million)
Table 57 Latin America: Market for Other Technologies, By Country/Region, 2016–2023 (USD Million)
Table 58 Market, By Application, 2016–2023 (USD Million)
Table 59 Market for Infectious Diseases, By Region, 2016–2023 (USD Million)
Table 60 North America: Market for Infectious Diseases, By Country/Region, 2016–2023 (USD Million)
Table 61 Europe: Market for Infectious Diseases, By Country/Region, 2016–2023 (USD Million)
Table 62 Asia Pacific: Market for Infectious Diseases, By Country/Region, 2016–2023 (USD Million)
Table 63 RoW: Market for Infectious Diseases, By Region, 2016–2023 (USD Million)
Table 64 Latin America: Market for Infectious Diseases, By Country/Region, 2016–2023 (USD Million)
Table 65 Molecular Diagnostics Market for Infectious Diseases, By Disease Type, 2016–2023 (USD Million)
Table 66 Hepatitis Diagnostics Market, By Region, 2016–2023 (USD Million)
Table 67 Hepatitis Diagnostics Market, By Region, 2016–2023 (Million Assays)
Table 68 HIV Diagnostics Market, By Region, 2016–2023 (USD Million)
Table 69 HIV Diagnostics Market, By Region, 2016–2023 (Million Assays)
Table 70 CT/NG Diagnostics Market, By Region, 2016–2023 (USD Million)
Table 71 CT/NG Diagnostics Market, By Region, 2016–2023 (Million Assays)
Table 72 HAI Diagnostics Market, By Region, 2016–2023 (USD Million)
Table 73 HAI Diagnostics Market, By Region, 2016–2023 (Million Assays)
Table 74 HPV Diagnostics Market, By Region, 2016–2023 (USD Million)
Table 75 HPV Diagnostics Market, By Region, 2016–2023 (Million Assays)
Table 76 TB Diagnostics Market, By Region, 2016–2023 (USD Million)
Table 77 TB Diagnostics Market, By Region, 2016–2023 (Million Assays)
Table 78 Influenza Diagnostics Market, By Region, 2016–2023 (USD Million)
Table 79 Influenza Diagnostics Market, By Region, 2016–2023 (Million Assays)
Table 80 Other Infectious Disease Diagnostics Market, By Region, 2016–2023 (USD Million)
Table 81 Molecular Diagnostics Market for Oncology, By Region, 2016–2023 (USD Million)
Table 82 North America: Market for Oncology, By Country, 2016–2023 (USD Million)
Table 83 Europe: Market for Oncology, By Country/Region, 2016–2023 (USD Million)
Table 84 Asia Pacific: Market for Oncology, By Country/Region, 2016–2023 (USD Million)
Table 85 RoW: Market for Oncology, By Region, 2016–2023 (USD Million)
Table 86 Latin America: Market for Oncology, By Country/Region, 2016–2023 (USD Million)
Table 87 Molecular Diagnostics Market for Oncology, By Cancer Type, 2016–2023 (USD Million)
Table 88 Breast Cancer Diagnostics Market, By Region, 2016–2023 (USD Million)
Table 89 Colorectal Cancer Diagnostics Market, By Region, 2016–2023 (USD Million)
Table 90 Lung Cancer Diagnostics Market, By Region, 2016–2023 (USD Million)
Table 91 Prostate Cancer Diagnostics Market, By Region, 2016–2023 (USD Million)
Table 92 Other Cancer Diagnostics Market, By Region, 2016–2023 (USD Million)
Table 93 Market for Genetic Testing, By Region, 2016–2023 (USD Million)
Table 94 North America: Market for Genetic Testing, By Country, 2016–2023 (USD Million)
Table 95 Europe: Market for Genetic Testing, By Country/Region, 2016–2023 (USD Million)
Table 96 Asia Pacific: Market for Genetic Testing, By Country/Region, 2016–2023 (USD Million)
Table 97 RoW: Market for Genetic Testing, By Region, 2016–2023 (USD Million)
Table 98 Latin America: Market for Genetic Testing, By Country/Region, 2016–2023 (USD Million)
Table 99 Market for Other Applications, By Region, 2016–2023 (USD Million)
Table 100 North America: Market for Other Applications, By Country, 2016–2023 (USD Million)
Table 101 Europe: Molecular Diagnostics Market for Other Applications, By Country, 2016–2023 (USD Million)
Table 102 Asia Pacific: Market for Other Applications, By Country/Region, 2016–2023 (USD Million)
Table 103 RoW: Market for Other Applications, By Region, 2016–2023 (USD Million)
Table 104 Latin America:Market for Other Applications, By Country/Region, 2016–2023 (USD Million)
Table 105 Market, By End User, 2016–2023 (USD Million)
Table 106 Molecular Diagnostics Market for Hospital & Academic Laboratories, By Region, 2016–2023 (USD Million)
Table 107 North America: Market for Hospital & Academic Laboratories, By Country, 2016–2023 (USD Million)
Table 108 Europe: Market for Hospital & Academic Laboratories, By Country/Region, 2016–2023 (USD Million)
Table 109 Asia Pacific: Market for Hospital & Academic Laboratories, By Country/Region, 2016–2023 (USD Million)
Table 110 RoW: Molecular Diagnostics Market for Hospital & Academic Laboratories, By Region, 2016–2023 (USD Million)
Table 111 Latin America: Market for Hospital & Academic Laboratories, By Country/Region, 2016–2023 (USD Million)
Table 112 Market for Reference Laboratories, By Region, 2016–2023 (USD Million)
Table 113 North America: Market for Reference Laboratories, By Country, 2016–2023 (USD Million)
Table 114 Europe: Market for Reference Laboratories, By Country/Region, 2016–2023 (USD Million)
Table 115 Asia Pacific: Market for Reference Laboratories, By Country/Region, 2016–2023 (USD Million)
Table 116 RoW: Molecular Diagnostics Market for Reference Laboratories, By Region, 2016–2023 (USD Million)
Table 117 Latin America: Market for Reference Laboratories, By Country/Region, 2016–2023 (USD Million)
Table 118 Molecular Diagnostics Market for Other End Users, By Region, 2016–2023 (USD Million)
Table 119 North America: Market for Other End Users, By Country, 2016–2023 (USD Million)
Table 120 Europe: Market for Other End Users, By Country/Region, 2016–2023 (USD Million)
Table 121 Asia Pacific: Market for Other End Users, By Country/Region, 2016–2023 (USD Million)
Table 122 RoW: Market for Other End Users, By Region, 2016–2023 (USD Million)
Table 123 Latin America: Market for Other End Users, By Country/Region, 2016–2023 (USD Million)
Table 124 Molecular Diagnostics Market, By Region, 2016–2023 (USD Million)
Table 125 North America: Market, By Product & Service, 2016–2023 (USD Million)
Table 126 North America: Market, By Technology, 2016–2023 (USD Million)
Table 127 North America: Market, By Application, 2016–2023 (USD Million)
Table 128 North America: Market, By End User, 2015–2023 (USD Million)
Table 129 North America: Molecular Diagnostics Market, By Country, 2016–2023 (USD Million)
Table 130 US: Molecular Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 131 US: Market, By Technology, 2016–2023 (USD Million)
Table 132 US: Market, By Application, 2016–2023 (USD Million)
Table 133 US: Market, By End User, 2016–2023 (USD Million)
Table 134 Canada: Market, By Product & Service, 2016–2023 (USD Million)
Table 135 Canada: Market, By Technology, 2016–2023 (USD Million)
Table 136 Canada: Market, By Application, 2016–2023 (USD Million)
Table 137 Canada: Market, By End User, 2016–2023 (USD Million)
Table 138 Europe: Market, By Product & Service, 2016–2023 (USD Million)
Table 139 Europe: Molecular Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 140 Europe: Market, By Application, 2016–2023 (USD Million)
Table 141 Europe: Market, By End User, 2016–2023 (USD Million)
Table 142 Europe: Market, By Country/Region, 2016–2023 (USD Million)
Table 143 Germany: Market, By Product & Service, 2016–2023 (USD Million)
Table 144 Germany: Market, By Technology, 2016–2023 (USD Million)
Table 145 Germany: Molecular Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 146 Germany: Market, By End User, 2016–2023 (USD Million)
Table 147 France: Market, By Product & Service, 2016–2023 (USD Million)
Table 148 France: Market, By Technology, 2016–2023 (USD Million)
Table 149 France: Market, By Application, 2016–2023 (USD Million)
Table 150 France: Market, By End User, 2016–2023 (USD Million)
Table 151 Italy: Molecular Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 152 Italy: Market, By Technology, 2016–2023 (USD Million)
Table 153 Italy: Molecular Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 154 Italy: Market, By End User, 2015–2023 (USD Million)
Table 155 Spain: Market, By Product & Service, 2016–2023 (USD Million)
Table 156 Spain: Market, By Technology, 2016–2023 (USD Million)
Table 157 Spain: Market, By Application, 2016–2023 (USD Million)
Table 158 Spain: Market, By End User, 2015–2023 (USD Million)
Table 159 UK: Molecular Diagnostics Market, By Product & Service, 2015–2023 (USD Million)
Table 160 UK: Market, By Technology, 2016–2023 (USD Million)
Table 161 UK: Market, By Application, 2016–2023 (USD Million)
Table 162 UK: Market, By End User, 2016–2023 (USD Million)
Table 163 RoE: Molecular Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 164 RoE: Market, By Technology, 2016–2023 (USD Million)
Table 165 RoE: Market, By Application, 2016–2023 (USD Million)
Table 166 RoE: Market, By End User, 2016–2023 (USD Million)
Table 167 Asia Pacific: Molecular Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 168 Asia Pacific: Market, By Technology, 2016–2023 (USD Million)
Table 169 Asia Pacific: Market, By Application, 2016–2023 (USD Million)
Table 170 Asia Pacific: Market, By End User, 2016–2023 (USD Million)
Table 171 Asia Pacific: Market, By Country/Region, 2016–2023 (USD Million)
Table 172 Japan: Molecular Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 173 Japan: Market, By Technology, 2016–2023 (USD Million)
Table 174 Japan: Molecular Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 175 Japan: Market, By End User, 2016–2023 (USD Million)
Table 176 China: Market, By Product & Service, 2016–2023 (USD Million)
Table 177 China: Market, By Technology, 2016–2023 (USD Million)
Table 178 China: Molecular Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 179 China: Market, By End User, 2016–2023 (USD Million)
Table 180 Australia: Market, By Product & Service, 2016–2023 (USD Million)
Table 181 Australia: Market, By Technology, 2016–2023 (USD Million)
Table 182 Australia: Market, By Application, 2016–2023 (USD Million)
Table 183 Australia: Market, By End User, 2016–2023 (USD Million)
Table 184 India: Market, By Product & Service, 2016–2023 (USD Million)
Table 185 India: Market, By Technology, 2016–2023 (USD Million)
Table 186 India: Market, By Application, 2016–2023 (USD Million)
Table 187 India: Market, By End User, 2016–2023 (USD Million)
Table 188 RoAPAC: Market, By Product & Service, 2016–2023 (USD Million)
Table 189 RoAPAC: Molecular Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 190 RoAPAC: Market, By Application, 2016–2023 (USD Million)
Table 191 RoAPAC: Market, By End User, 2016–2023 (USD Million)
Table 192 RoW: Molecular Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 193 RoW: Market, By Technology, 2016–2023 (USD Million)
Table 194 RoW: Market, By Application, 2016–2023 (USD Million)
Table 195 RoW: Market, By End User, 2016–2023 (USD Million)
Table 196 RoW: Market, By Region, 2016–2023 (USD Million)
Table 197 Latin America: Molecular Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 198 Latin America: Market, By Technology, 2016–2023 (USD Million)
Table 199 Latin America: Molecular Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 200 Latin America: Market, By End User, 2016–2023 (USD Million)
Table 201 Latin America:Market, By Country/Region, 2016–2023 (USD Million)
Table 202 Brazil: Molecular Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 203 Brazil: Market, By Technology, 2016–2023 (USD Million)
Table 204 Brazil: Market, By Application, 2016–2023 (USD Million)
Table 205 Brazil: Market, By End User, 2016–2023 (USD Million)
Table 206 Mexico: Market, By Product & Service, 2016–2023 (USD Million)
Table 207 Mexico: Molecular Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 208 Mexico: Market, By Application, 2016–2023 (USD Million)
Table 209 Mexico: Market, By End User, 2016–2023 (USD Million)
Table 210 RoLA: Market, By Product & Service, 2016–2023 (USD Million)
Table 211 RoLA: Market, By Technology, 2016–2023 (USD Million)
Table 212 RoLA: Market, By Application, 2016–2023 (USD Million)
Table 213 RoLA: Market, By End User, 2016–2023 (USD Million)
Table 214 Middle East & Africa: Molecular Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 215 Middle East & Africa: Market, By Technology, 2016–2023 (USD Million)
Table 216 Middle East & Africa: Market, By Application, 2016–2023 (USD Million)
Table 217 Middle East & Africa: Molecular Diagnostics Market, By End User, 2016–2023 (USD Million)
Table 218 New Product Launches and Approvals, 2016–2018
Table 219 Agreements, Partnerships, and Collaborations, 2016–2018
Table 220 Acquisitions and Mergers 2016–2018
Table 221 Expansions, 2016–2018


List of Figures (38 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Data Triangulation
Figure 6 Molecular Diagnostics Market, By Product and Service, 2018 vs 2023
Figure 7 Market, By Application, 2018 vs 2023
Figure 8 Market, By Technology, 2018 vs 2023
Figure 9 Market, By End User, 2018 vs 2023
Figure 10 Geographical Snapshot of the Molecular Diagnostics Market
Figure 11 Increasing Prevalence of Infectious Diseases and Various Types of Cancers — Key Drivers for the Market
Figure 12 PCR Technology to Account for the Largest Market Share in 2018
Figure 13 Reagents and Kits to Dominate the Market in 2023
Figure 14 Hospital and Academic Laboratories to Account for the Largest Share in 2018
Figure 15 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 DNA Sequencing & NGS to Witness the Highest Growth During the Forecast Period (2018–2023)
Figure 17 Geographical Snapshot: Asia Pacific to Be the Fastest-Growing Regional Segment in the Molecular Diagnostics Market
Figure 18 North America: Market Snapshot
Figure 19 Asia Pacific: Market Snapshot
Figure 20 Companies Adopted Product Launches as Their Key Growth Strategy Over the Last Three Years
Figure 21 Global Market Share, By Key Player, 2017
Figure 22 Global Infectious Disease Diagnostics Market Ranking, By Key Player, 2017
Figure 23 Global Market for PCR, Market Share Analysis, By Key Player 2016
Figure 24 Global Market for DNA Sequencing and NGS, Market Share Analysis, By Key Player, 2016
Figure 25 Global Market for ISH, By Key Player, 2016
Figure 26 Abbott Laboratories: Company Snapshot
Figure 27 Agilent Technologies: Company Snapshot
Figure 28 Becton, Dickinson and Company: Company Snapshot
Figure 29 Biomιrieux Sa: Company Snapshot
Figure 30 Danaher Corporation: Company Snapshot
Figure 31 Diasorin: Company Snapshot
Figure 32 Grifols: Company Snapshot
Figure 33 Hologic: Company Snapshot
Figure 34 Illumina: Company Snapshot
Figure 35 Qiagen: Company Snapshot (2017)
Figure 36 Roche Diagnostics: Company Snapshot
Figure 37 Siemens AG: Company Snapshot
Figure 38 Thermo Fisher Scientific: Company Snapshot

The global molecular diagnostics market is projected to reach USD 11.54 Billion by 2023 from USD 7.71 Billion in 2018, at CAGR of 8.4%.

Molecular diagnostics is a technique used to identify and analyze nucleic acids or proteins at a molecular level. This technique assesses the genetic makeup of an individual to identify predisposition to a particular disease or condition and diagnose it. Growth in this market is largely driven by the high prevalence of infectious diseases and various types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market, and advancements in molecular techniques. On the other hand, the presence of complex regulatory frameworks for the approval of molecular diagnostic tests is one of the major factors restraining the growth of this market.

In this report, the market has been segmented on the basis of product and service, application, technology, end user, and region.

On the basis of product and service, the market is broadly segmented into reagents and kits, instruments, and services and software. The reagents and kits segment is expected to account for the largest share of the global market in 2018 and is projected to register the highest CAGR during the forecast period. The availability of a wide range of reagents and kits, rising use of reagents and kits in different therapeutic areas (such as infectious diseases and oncology), increase in basic research and commercial applications, and easy accessibility to a wide range of reagents are expected to drive the market for molecular diagnostic reagents and kits in the coming years.

Based on application, the market is segmented into infectious diseases, oncology, genetic tests, and other applications. The infectious diseases segment is expected to account for the largest share of the global market in 2018. The large share of this segment can be attributed to the development of advanced assays for different diseases and conditions, significant increase in the prevalence of infectious diseases, and rising awareness about the effective use of molecular diagnostic technologies or products to control the occurrence and spread of infectious diseases.

Based on technology, the market is segmented into PCR, INAAT, DNA sequencing & NGS, in situ hybridization, DNA microarrays, and other technologies. In 2018, the PCR segment is expected to account for the largest share of the global market. The large share of this segment can be attributed to the growing use of PCR in proteomics and genomics, automation of PCR instruments, and the emergence of advanced technologies like qRT-PCR.

On the basis of end user, the market is segmented into hospitals and academic laboratories, reference laboratories, and other end users. In 2018, the hospitals and academic laboratories segment is expected to account for the largest share of the global market. The large share of this segment can primarily be attributed to the large number of diagnostic tests conducted in hospitals.

In 2018, North America is expected to account for the largest share of the global molecular diagnostics market. The large share of this region can be attributed to factors such as the high prevalence of infectious diseases and cancers in the region, presence of a highly developed healthcare system and large number of leading national clinical laboratories, easy accessibility to technologically advanced instruments, availability of government funds, and growing applications of molecular diagnostics in genetic disorders and cancer screening.

Molecular Diagnostics Market

The key players in the global market are Roche (Switzerland), Hologic (US), QIAGEN (Netherlands), Abbott (US), and Danaher (US). These players focus on inorganic strategies such as acquisitions, partnerships, agreements, and collaborations as well as organic strategies such as expansions and product launches & approvals to sustain their positions in the market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth In-Vitro Diagnostics Markets on KnowledgeStore
Request Demo